| Entry |
|
|---|
| Name |
Clindamycin palmitate hydrochloride (JAN/USP);
Cleocin pediatric (TN) |
|---|
| Product |
|
|---|
| Generic |
CLEOCIN PEDIATRIC (Pharmacia & Upjohn Company LLC), CLINDAMYCIN PALMITATE HYDROCHLORIDE (Amneal Pharmaceuticals LLC), CLINDAMYCIN PALMITATE HYDROCHLORIDE (Amneal Pharmaceuticals of New York LLC), CLINDAMYCIN PALMITATE HYDROCHLORIDE (Bryant Ranch Prepack), CLINDAMYCIN PALMITATE HYDROCHLORIDE (Bryant Ranch Prepack), CLINDAMYCIN PALMITATE HYDROCHLORIDE (Bryant Ranch Prepack), CLINDAMYCIN PALMITATE HYDROCHLORIDE (Bryant Ranch Prepack), CLINDAMYCIN PALMITATE HYDROCHLORIDE (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals), CLINDAMYCIN PALMITATE HYDROCHLORIDE (PEDIATRIC) (Aurobindo Pharma Limited), CLINDAMYCIN PALMITATE HYDROCHLORIDE (PEDIATRIC) (NorthStar Rx LLC), CLINDAMYCIN PALMITATE HYDROCHLORIDE (Padagis US LLC), CLINDAMYCIN PALMITATE HYDROCHLORIDE (Rising Pharma Holdings) |
|---|
| Formula |
C34H63ClN2O6S. HCl
|
|---|
| Exact mass |
698.3862
|
|---|
| Mol weight |
699.85
|
|---|
| Structure |
|
|---|
| Simcomp |
|
|---|
| Class |
Antibacterial
DG01578 Lincosamide antibiotic
|
|---|
| Remark |
| Product (DG00435): | D00277<US> D01073<JP/US> D01990<US> D02132<JP/US> |
|
|---|
| Efficacy |
Antibacterial, Protein biosynthesis inhibitor |
|---|
| Disease |
Infections due to susceptible strains of streptococci [DS: H00333] Infections due to susceptible strains of staphylococci [DS: H01175] |
|---|
| Comment |
Semisynthetic lincosamide
Active form of prodrug: Clindamycin [DR: D00277]
|
|---|
| Target |
50S ribosomal subunit |
|---|
| Pathway |
|
|---|
| Interaction |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
D DERMATOLOGICALS
D10 ANTI-ACNE PREPARATIONS
D10A ANTI-ACNE PREPARATIONS FOR TOPICAL USE
D10AF Antiinfectives for treatment of acne
D10AF01 Clindamycin
D01990 Clindamycin palmitate hydrochloride (JAN/USP) <US>
G GENITO URINARY SYSTEM AND SEX HORMONES
G01 GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS
G01A ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS
G01AA Antibiotics
G01AA10 Clindamycin
D01990 Clindamycin palmitate hydrochloride (JAN/USP) <US>
J ANTIINFECTIVES FOR SYSTEMIC USE
J01 ANTIBACTERIALS FOR SYSTEMIC USE
J01F MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS
J01FF Lincosamides
J01FF01 Clindamycin
D01990 Clindamycin palmitate hydrochloride (JAN/USP) <US>
USP drug classification [BR:br08302]
Antibacterials
Antibacterials, Other
Clindamycin
D01990 Clindamycin palmitate hydrochloride (JAN/USP)
Dermatological Agents
Topical Anti-infectives
Antibacterials, Dermatological
Clindamycin
D01990 Clindamycin palmitate hydrochloride (JAN/USP)
Drug groups [BR:br08330]
Antibacterial
DG01578 Lincosamide antibiotic
DG00435 Clindamycin
D01990 Clindamycin palmitate hydrochloride
Drug classes [BR:br08332]
Antibacterial
DG01578 Lincosamide antibiotic
D01990 Clindamycin palmitate hydrochloride
Antimicrobials [BR:br08307]
Antibacterials
Protein biosynthesis inhibitor
Lincosamide
D01990 Clindamycin palmitate hydrochloride (JAN/USP) <US>
Prodrugs [br08324.html]
D01990
Drug groups [BR:br08330]
Antibacterial
DG01578 Lincosamide antibiotic
DG00435 Clindamycin
Antimicrobials abbreviations [BR:br08327]
Antibacterials
Protein biosynthesis inhibitor
Lincosamide
DG00435 Clindamycin
Prodrugs [br08324.html]
DG00435
|
|---|
| Other DBs |
|
|---|
| KCF data |
ATOM 45
1 C1y C 10.6416 -15.4011
2 C1y C 10.6416 -16.8012
3 C1y C 11.8541 -17.5012
4 C1y C 13.0667 -16.8012
5 C1y C 13.0667 -15.4011
6 O2x O 11.8541 -14.7011
7 S2a S 14.2805 -14.7003
8 C1a C 14.2805 -13.3009
9 O7a O 14.2825 -17.5023
10 C7a C 15.4952 -16.8023
11 C1b C 16.7079 -17.5023
12 C1b C 17.9205 -16.8023
13 C1b C 19.1331 -17.5023
14 C1b C 20.3458 -16.8023
15 C1b C 21.5584 -17.5023
16 C1b C 22.7710 -16.8023
17 C1b C 23.9836 -17.5023
18 C1b C 25.1962 -16.8023
19 C1b C 26.4088 -17.5023
20 C1b C 27.6214 -16.8023
21 C1b C 28.8340 -17.5023
22 C1b C 30.0466 -16.8023
23 C1b C 31.2593 -17.5023
24 C1b C 32.4718 -16.8023
25 C1a C 33.6846 -17.5023
26 O1a O 11.8541 -18.9026
27 O1a O 9.4295 -17.5009
28 C1c C 9.4304 -14.7018
29 N1b N 8.2170 -15.4023
30 C1c C 9.4304 -13.3017
31 X Cl 8.2171 -12.6012
32 C1a C 10.6423 -12.6020
33 C5a C 7.0033 -14.7020
34 C1y C 5.7906 -15.4020
35 O5a O 7.0031 -13.3017
36 N1y N 4.5099 -14.8319
37 C1x C 3.5720 -15.8736
38 C1y C 4.2728 -17.0877
39 C1x C 5.6441 -16.7962
40 C1a C 4.2218 -13.4758
41 C1b C 3.7093 -18.3540
42 C1b C 2.2975 -18.5028
43 C1a C 1.7342 -19.7685
44 O6a O 15.4952 -15.3995
45 X Cl 36.7255 -16.3329
BOND 45
1 1 2 1
2 2 3 1
3 3 4 1
4 4 5 1
5 5 6 1
6 1 6 1
7 5 7 1 #Down
8 7 8 1
9 4 9 1 #Down
10 9 10 1
11 10 11 1
12 11 12 1
13 12 13 1
14 13 14 1
15 14 15 1
16 15 16 1
17 16 17 1
18 17 18 1
19 18 19 1
20 19 20 1
21 20 21 1
22 21 22 1
23 22 23 1
24 23 24 1
25 24 25 1
26 3 26 1 #Up
27 2 27 1 #Up
28 1 28 1
29 28 29 1
30 28 30 1
31 30 31 1 #Up
32 30 32 1
33 29 33 1
34 34 33 1 #Down
35 33 35 2
36 34 36 1
37 36 37 1
38 37 38 1
39 38 39 1
40 34 39 1
41 36 40 1
42 38 41 1 #Up
43 41 42 1
44 42 43 1
45 10 44 2
|
|---|
